June 17, 2011
A Delaware federal judge dismissed AstraZeneca Pharmaceuticals LP's patent suit against Teva Pharmaceuticals USA Inc. on Thursday, after Teva withdrew its application to make a generic version of AstraZeneca's breast cancer drug Faslodex.